The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
ABC of oral bioavailability: transporters as gatekeepers in the gut
Open accessAbstract
MDR1 (ABCB1), MRP2 (ABCC2), and BCRP (ABCG2) are members of the family of ATP binding cassette (ABC) transporters. These are plasma membrane transporters that are expressed in various organs. The role of MDR1 and MRP2 in the hepatobiliary system is well defined; both contribute to bile formation by transport of drugs, toxins, and waste products across the canalicular membrane. As they transport exogenous and endogenous substances, they reduce the body load of potentially harmful compounds. The role of ABCG2, which is also expressed in the canalicular membrane of hepatocytes, has not yet been fully characterised. All three proteins are also expressed in the apical membrane of enterocytes where they probably control oral availability of many substances. This important "gatekeeper" function of ABC transporters has been recognised recently and is currently under further investigation. Expression and activity of these transporters in the gut may differ between individuals, due to genetic polymorphisms or pathological conditions. This will lead to individual differences in bioavailability of different drugs, toxins, and (food derived) carcinogens. Recent information on substrates, transport mechanisms, function, and regulation of expression of MDR1, MRP2, and BCRP in different species is summarised in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H. P., Brockmöller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3473 · Cited by 2,365
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
Tukey, R. H., & Strassburg, C. P. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.581 · Cited by 1,523
Schinkel, A. H., Wagenaar, E., Mol, C. A., & van Deemter, L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118699 · Cited by 1,264
Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C. L. M., Schinkel, A. H., van de Vijver, M. J., Scheper, R. J., & Schellens, J. H. M. (2001) · PubMed · Cited by 1,130
Kim, R. B., Fromm, M. F., Wandel, C., Leake, B., Wood, A. J., Roden, D. M., & Wilkinson, G. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1269 · Cited by 1,054
Identification of functionally variant MDR1 alleles among European Americans and African Americans
Kim, R. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.117412 · Cited by 1,009
Cytochromes P450: a success story.
Werck‐Reichhart, D., & Feyereisen, R. (2000) · Genome biology · doi:10.1186/gb-2000-1-6-reviews3003 · Cited by 1,004
Miyake, K., Mickley, L. A., Litman, T., Zhan, Z., Robey, R. W., Cristensen, B., Brangi, M., Greenberger, L., Dean, M. C., Fojo, T., et al. (1999) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 929
SXR, a novel steroid and xenobioticsensing nuclear receptor
Blumberg, B., Sabbagh, W., Juguilon, H., Bolado, J., van Meter, C. M., Ong, E. S., & Evans, R. M. (1998) · Genes & Development · doi:10.1101/gad.12.20.3195 · Cited by 919
Kast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., Tontonoz, P., Kliewer, S., Willson, T. M., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109326200 · Cited by 916
Cytochromes P450 and metabolism of xenobiotics
Anzenbacher, P., & Anzenbacherová, E. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000897 · Cited by 889
Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin
Geick, A., Eichelbaum, M., & Burk, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010173200 · Cited by 848
Jonker, J. W., Buitelaar, M., Wagenaar, E., van der Valk, M. A., Scheffer, G. L., Scheper, R. J., Plösch, T., Kuipers, F., Elferink, R. P. J. O., Rosing, H., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202607599 · Cited by 822
Self-citationThe Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity
Watkins, R. E., Wisely, G. B., Moore, L. B., Collins, J. L., Lambert, M. H., Williams, S. P., Willson, T. M., Kliewer, S. A., & Redinbo, M. R. (2001) · Science · doi:10.1126/science.1060762 · Cited by 760
Cascorbi, I. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.114164 · Cited by 747
Lown, K. S., Mayo, R. R., Leichtman, A. B., Hsiao, H.-L., Turgeon, D. K., Schmiedlin-Ren, P., Brown, M. B., Guo, W., Rossi, S. J., Benet, L. Z., et al. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90027-8 · Cited by 680
Fellay, J., Marzolini, C., Meaden, E. R., Back, D. J., Buclin, T., Chave, J.-P., Decosterd, L. A., Furrer, H., Opravil, M., Pantaleo, G., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07276-8 · Cited by 658
The ATP-dependent glutathione S-conjugate export pump
Ishikawa, T. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90489-v · Cited by 654
Maglich, J. M., Stoltz, C. M., Goodwin, B., Hawkins-Brown, D., Moore, J. T., & Kliewer, S. A. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.638 · Cited by 654
Role of Breast Cancer Resistance Protein in the Bioavailability and Fetal Penetration of Topotecan
Jonker, J. W. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.20.1651 · Cited by 638
Hoffmeyer, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050585397 · Cited by 599
St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4
Dürr, D. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.112240 · Cited by 584
Panwala, C. M., Jones, J. C., & Viney, J. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5733 · Cited by 567
Reciprocal activation of Xenobiotic response genes by nuclear receptors SXR/PXR and CAR
Xie, W., Barwick, J. L., Simon, C. M., Pierce, A. M., Safe, S., Blumberg, B., Guzelian, P. S., & Evans, R. M. (2000) · Genes & Development · doi:10.1101/gad.846800 · Cited by 508
Zhou, S., Morris, J. J., Barnes, Y., Lan, L., Schuetz, J. D., & Sorrentino, B. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192276999 · Cited by 502
The physiological function of drug-transporting P-glycoproteins
Schinkel, A. H. (1997) · Seminars in Cancer Biology · doi:10.1006/scbi.1997.0068 · Cited by 458
Interrelationship Between Substrates and Inhibitors of Human CYP3A and P-Glycoprotein
Kirn, R. B., Wandel, C., Leake, B., Cvetkovic, M., Fromm, M. F., Dempsey, P. J., Roden, M. M., Belas, F., Chaudhary, A. K., Roden, D. M., et al. (1999) · Pharmaceutical Research · doi:10.1023/a:1018877803319 · Cited by 454
Taipalensuu, J., Törnblom, H., Lindberg, G., Einarsson, C., Sjöqvist, F., Melhus, H., Garberg, P., Sjöström, B., Lundgren, B., & Artursson, P. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29314-9 · Cited by 444
Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2.
Hooijberg, J. H., Broxterman, H. J., Kool, M., Assaraf, Y. G., Peters, G. J., Noordhuis, P., Scheper, R. J., Borst, P., Pinedo, H. M., & Jansen, G. (1999) · PubMed · Cited by 442
Honjo, Y., Hrycyna, C. A., Yan, Q. W., Medina-Pérez, W. Y., Robey, R. W., van de Laar, A., Litman, T., Dean, M. C., & Bates, S. E. (2001) · PubMed · Cited by 429
Increased drug delivery to the brain by P-glycoprotein inhibition
Sadeque, A. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.109156 · Cited by 426
Wacher, V. J., Silverman, J. A., Zhang, Y., & Benet, L. Z. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980082d · Cited by 423
Loe, D. W., Deeley, R. G., & Cole, S. P. C. (1998) · PubMed · Cited by 394
Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport
Oude Elferink, R. P. J., Meijer, D. K. F., Kuipers, F., Jansen, P. L. M., Groen, A. K., & Groothuis, G. M. M. (1995) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(95)00006-d · Cited by 386
Self-citationExpression of members of the multidrug resistance protein family in human term placenta
St-Pierre, M. V., Serrano, M. A., Macias, R. I. R., Dubs, U., Hoechli, M., Lauper, U., Meier, P. J., & Marin, J. J. G. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.4.r1495 · Cited by 325
Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis
Schwab, M., Schaeffeler, E., Marx, C., Fromm, M. F., Kaskas, B., Metzler, J., Stange, E., Herfarth, H., Schoelmerich, J., Gregor, M., et al. (2003) · Gastroenterology · doi:10.1053/gast.2003.50010 · Cited by 323
Interactions of the Human Multidrug Resistance Proteins MRP1 and MRP2 with Organic Anions
Bakos, É., Evers, R., Sinkó, E., Váradi, A., Borst, P., & Sarkadi, B. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26477-4 · Cited by 322
Kala, S. V., Neely, M. W., Kala, G., Prater, C. I., Atwood, D. W., Rice, J. S., & Lieberman, M. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007030200 · Cited by 317
Xenobiotic Transport across Isolated Brain Microvessels Studied by Confocal Microscopy
Miller, D. S., Nobmann, S. N., Gutmann, H., Toeroek, M., Drewe, J., & Fricker, G. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12708-3 · Cited by 307
Suzuki, H., & Sugiyama, Y. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00178-0 · Cited by 291
Ueda, K., Pastan, I., & Gottesman, M. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45397-5 · Cited by 286
Westphal, K. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.109797 · Cited by 285
The Effect of Rifampin Treatment on Intestinal Expression of Human MRP Transporters
Fromm, M. F., Kauffmann, H.-M., Fritz, P., Burk, O., Kroemer, H. K., Warzok, R. W., Eichelbaum, M., Siegmund, W., & Schrenk, D. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64794-3 · Cited by 277
Role of P-Glycoprotein in Drug Disposition
Tanigawara, Y. (2000) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200002000-00029 · Cited by 261
Walle, U. K., Galijatovic, A., & Walle, T. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00133-1 · Cited by 251
MDR1 gene polymorphisms and disposition of the P‐glycoprotein substrate fexofenadine
Drescher, S., Schaeffeler, E., Hitzl, M., Hofmann, U., Schwab, M., Brinkmann, U., Eichelbaum, M., & Fromm, M. F. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01591.x · Cited by 249
Siegsmund, M., Brinkmann, U., Scha[Combining Acute Accent]ffeler, E., Weirich, G., Schwab, M., Eichelbaum, M., Fritz, P., Burk, O., Decker, J., Alken, P., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000019412.87412.bc · Cited by 246
Expression and Localization of Multidrug Resistant Protein mrp2 in Rat Small Intestine
Mottino, A. D., Hoffman, T., Jennes, L., & Vore, M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39291-2 · Cited by 239
St John's wort, a herbal antidepressant, activates the steroid X receptor
Wentworth, J., Agostini, M., Love, J., Schwabe, J., & Chatterjee, V. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.166r011 · Cited by 236
Effect of grapefruit juice on digoxin pharmacokinetics in humans.
Becquemont, L., Verstuyft, C., Kerb, R., Brinkmann, U., Lebot, M., Jaillon, P., & Funck‐Brentano, C. (2001) · PubMed · Cited by 234
Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein
Pauli-Magnus, C., Rekersbrink, S., Klotz, U., & Fromm, M. F. (2001) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-001-0489-7 · Cited by 230
Clinical trials of agents that reverse multidrug resistance. A literature review
Raderer, M., & Scheithauer, W. (1993) · Cancer · doi:10.1002/1097-0142(19931215)72:12<3553::aid-cncr2820721203>3.0.co;2-b · Cited by 228
Evers, R., de Haas, M., Sparidans, R., Beijnen, J., Wielinga, P. R., Lankelma, J., & Borst, P. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1262 · Cited by 227
Bailey-Dell, K. J., Hassel, B., Doyle, L. A., & Ross, D. D. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(01)00270-6 · Cited by 225
Fricker, G., Drewe, J., Huwyler, J., Gutmann, H., & Beglinger, C. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15612.x · Cited by 223
Wandel, C., Kim, R., Wood, M., & Wood, A. (2002) · Anesthesiology · doi:10.1097/00000542-200204000-00019 · Cited by 215
Cui, Y., König, J., & Keppler, D. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12502-3 · Cited by 206
Zelcer, N., Huisman, M. T., Reid, G., Wielinga, P., Breedveld, P., Kuil, A., Knipscheer, P., Schellens, J. H. M., Schinkel, A. H., & Borst, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303504200 · Cited by 200
Grapefruit Juice Activates P-Glycoprotein-Mediated Drug Transport
Soldner, A., Christians, U., Susanto, M., Wacher, V. J., Silverman, J. A., & Benet, L. Z. (1999) · Pharmaceutical Research · doi:10.1023/a:1011902625609 · Cited by 193
Peptide Mimetic HIV Protease Inhibitors Are Ligands for the Orphan Receptor SXR
Dussault, I., Lin, M., Hollister, K., Wang, E. H., Synold, T. W., & Forman, B. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100375200 · Cited by 189
Denson, L. A., Auld, K. L., Schiek, D. S., McClure, M. H., Mangelsdorf, D. J., & Karpen, S. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8835 · Cited by 187
Vaidyanathan, J. B., & Walle, T. (2001) · Pharmaceutical Research · doi:10.1023/a:1012200805593 · Cited by 184
Interactions of HIV Protease Inhibitors with ATP-Dependent Drug Export Proteins
Gutmann, H., Fricker, G., Drewe, J., Toeroek, M., & Miller, D. S. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12649-1 · Cited by 180
Role of MRP2 and GSH in intrahepatic cycling of toxins
Dietrich, C. (2001) · Toxicology · doi:10.1016/s0300-483x(01)00459-0 · Cited by 177
Self-citationClinical trials of agents that reverse multidrug-resistance.
Gottesman, M. M., & Pastan, I. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.4.409 · Cited by 176
Bodó, A., Bakos, É., Szeri, F., Váradi, A., & Sarkadi, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303515200 · Cited by 166
Rost, D., Mahner, S., Sugiyama, Y., & Stremmel, W. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00318.2001 · Cited by 166
Kawabe, T., Chen, Z.-S., Wada, M., Uchiumi, T., Ono, M., Akiyama, S.-I., & Kuwano, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00979-5 · Cited by 158
Takanaga, H., Ohnishi, A., Yamada, S., Matsuo, H., Morimoto, S., Shoyama, Y., Ohtani, H., & Sawada, Y. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39224-9 · Cited by 149
The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels
Kerb, R., Aynacioglu, A. S., Brockmöller, J., Schlagenhaufer, R., Bauer, S., Szekeres, T., Hamwi, A., Fritzer-Szekeres, M., Baumgärtner, C., Ongen, H. Z., et al. (2001) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500025 · Cited by 135
Dietrich, C. G., de Waart, D. R., Ottenhoff, R., Schoots, I. G., & Elferink, R. P. J. O. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.974 · Cited by 131
Self-citationRegulation of UDP Glucuronosyltransferase Genes
Mackenzie, P. I., Gregory, P. A., Gardner-Stephen, D. A., et al. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489442 · Cited by 129
Up-regulation of transporters of the MRP family by drugs and toxins
Schrenk, D., Baus, P. R., Ermel, N., Klein, C., Vorderstemann, B., & Kauffmann, H.-M. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(01)00306-x · Cited by 125
van der Sandt, I. V. D., Blom-Roosemalen, M. C., de Boer, A. G., & Breimer, D. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00097-x · Cited by 115
Multidrug resistance mediated by P-glycoproteins.
Schinkel, A. H., & Borst, P. (1991) · PubMed · Cited by 112
Schellens, J. H. M., Maliepaard, M., Scheper, R. J., Scheffer, G. L., Jonker, J. W., Smit, J. W., Beijnen, J. H., & Schinkel, A. H. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb07037.x · Cited by 111
Inhibition of P-Glycoprotein Transport Function by Grapefruit Juice Psoralen
Wang, E., Casciano, C. N., Clement, R. P., & Johnson, W. W. (2001) · Pharmaceutical Research · doi:10.1023/a:1011089924099 · Cited by 106
Tanaka, T., Uchiumi, T., Hinoshita, E., Inokuchi, A., Toh, S., Wada, M., Takano, H., Kohno, K., & Kuwano, M. (1999) · Hepatology · doi:10.1002/hep.510300617 · Cited by 101
Payen, L. F., Delugin, L., Courtois, A., Trinquart, Y., Guillouzo, A., & Fardel, O. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703863 · Cited by 97
Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice.
Yamada, T., Mori, Y., Hayashi, R., Takada, M., Ino, Y., Naishiro, Y., Kondo, T., & Hirohashi, S. (2003) · PubMed · Cited by 97
Kornblau, S. M., Estey, E. H., Madden, T. L., Tran, H. T., Zhao, S., Consoli, U., Snell, V., Sanchez‐Williams, G., Kantarjian, H. M., Keating, M. J., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.1796 · Cited by 89
Engman, H., Lennernäs, H., Taipalensuu, J., Otter, C. A., Leidvik, B., & Artursson, P. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1123 · Cited by 89
Dietrich, C. G. (2001) · Carcinogenesis · doi:10.1093/carcin/22.5.805 · Cited by 85
Self-citationWandel, C., Kim, R. B., Guengerich, F. P., & Wood, A. J. J. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15160-4 · Cited by 85
Denson, L. A., Bohan, A., Held, M. A., & Boyer, J. L. (2002) · Gastroenterology · doi:10.1053/gast.2002.34758 · Cited by 84
Perego, P., Cesare, M. D., Isabella, P. D., Carenini, N., Beggiolin, G., Pezzoni, G., Palumbo, M., Tartaglia, L., Pratesi, G., Pisano, C., et al. (2001) · PubMed · Cited by 83
Interaction of Docetaxel (“Taxotere”) with Human P‐Glycoprotein
Shirakawa, K., Takara, K., Tanigawara, Y., Aoyama, N., Kasuga, M., Komada, F., Sakaeda, T., & Okumura, K. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00723.x · Cited by 79
Regulation of biliary drug efflux pump expression by hormones and xenobiotics
Fardel, O., Payen, L., Courtois, A., Vernhet, L., & Lecureur, V. (2001) · Toxicology · doi:10.1016/s0300-483x(01)00456-5 · Cited by 72
Smith, A. J., Mayer, U., Schinkel, A. H., & Borst, P. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.15.1161 · Cited by 72
Kauffmann, H.-M., KEPPLER, D. O. R., Gant, T. W., & Schrenk, D. (1998) · Archives of Toxicology · doi:10.1007/s002040050571 · Cited by 71
Preserved organic anion transport in mutant TR- rats with a hepatobiliary secretion defect
Jansen, P. L. M., van Klinken, J. W., van Gelder, M., Ottenhoff, R., & Elferink, R. P. J. O. (1993) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1993.265.3.g445 · Cited by 68
Multiple pathways for fluoroquinolone secretion by human intestinal epithelial (Caco‐2) cells
Lowes, S., & Simmons, N. L. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704560 · Cited by 67
Up‐Regulation of P‐Glycoprotein Expression in Rat Liver Cells by Acute Doxorubicin Treatment
Fardel, O., Lecureur, V., Daval, S., Corlu, A., & Guillouzo, A. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-1-00186.x · Cited by 65
Transcriptional Control of Hepatocanalicular Transporter Gene Expression
Müller, M. M. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9387 · Cited by 55
Simvastatin and lovastatin, but not pravastatin, interact with MDR1
Sakaeda, T., Takara, K., Kakumoto, M., Ohmoto, N., Nakamura, T., Iwaki, K., Tanigawara, Y., & Okumura, K. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021778493 · Cited by 52
P‐glycoprotein‐ and mrp2‐mediated octreotide transport in renal proximal tubule
Gutmann, H., Miller, D. S., Droulle, A., Drewe, J., Fahr, A., & Fricker, G. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703003 · Cited by 51
P-glycoprotein-mediated transport of digitoxin, α-methyldigoxin and β-acetyldigoxin
Pauli‐Magnus, C., Mürdter, T. E., Godel, A., Mettang, T., Eichelbaum, M., Klotz, U. E., & Fromm, M. F. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000354 · Cited by 49
Flanagan, S. D., Cummins, C. L., Susanto, M., Liu, X., Takahashi, L. H., & Benet, L. Z. (2002) · Pharmacology · doi:10.1159/000056161 · Cited by 48
Geier, A., Mertens, P. R., Gerloff, T., Dietrich, C. G., En‐Nia, A., Kullak-Ublick, G. A., KARPEN, S., Matern, S., & Gartung, C. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.041 · Cited by 28
Self-citation
Cited by
Leslie, E. M., Deeley, R. G., & Cole, S. P. C. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.012 · Cited by 1,406
Sarkadi, B., Homolya, L., Szakács, G., & Váradi, A. (2006) · Physiological Reviews · doi:10.1152/physrev.00037.2005 · Cited by 726
Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
Alfarouk, K. O., Stock, C.-M., Taylor, S., Walsh, M., Muddathir, A. K., Verduzco, D., Bashir, A. H. H., Mohammed, O. Y., Elhassan, G. O., Harguindey, S., et al. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0221-1 · Cited by 665
Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging
SCHILLER, C., FRÖHLICH, C. ‐., GIESSMANN, T., SIEGMUND, W., MÖNNIKES, H., HOSTEN, N., & WEITSCHIES, W. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02683.x · Cited by 596
Hilgendorf, C., Ahlin, G., Seithel, A., Artursson, P., Ungell, A.-L., & Karlsson, J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.014902 · Cited by 583
Metadata
- Authors
- Dietrich, C. G., Geier, A., & Oude Elferink, R. P. J.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2003-11-21
- Volume
- 52
- Issue
- 12
- Pages
- 1788-1795
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2123467745
- Cited by
- 317
- References
- 100
- FWCI
- 7.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.